Positive outcomes from the international bone marrow registry database in patients aged 50+ with AA

Stem cell transplant is a very feasible option in a good proportion of patients who might be elderly, but are otherwise fit and healthyRead more

T-reg cells offer hope for aplastic anaemia patients

Revolutionary discovery of treatment using T-regulatory cellsRead more

Positive reports from extended use of Eltrombopag

Encouraging results from a study into the use of Eltrombopag show that extended use of the drug at a fixed dose could speed and improve patients' response ratesRead more

Promising results from Eculizumab trials for patients with PNH

Eculizumab has revolutionised the treatment of PNH, offering freedom from blood transfusion and independence to a large number of patientsRead more

Phase 1 study on combining BL8040 compound with IST

News from the 23rd Annual Congress of the European Haematology Association on an exciting study taking place at the MD Anderson Cancer Centre in TexasRead more

Eltrombopag use as a single agent

More news from the 23rd Annual Congress of the European Haematology Association (EHA) in Stockholm. Here is the feedback on the use of Eltrombopag as a single agentRead more

Eculizumab used in the treatment of PNH

A final piece of news from the 23rd Annual Congress of the European Haematology Association on the use of Eculizumab in PNHRead more

Results of an early study of CXCR4-blocking drug BL-8040, combined with immune-suppressive therapy

Encouraging to see new compounds being tested in the treatment of aplastic anaemia, narrated by Dr Laura Jardine, Newcastle UniversityRead more